Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis

Blood Cancer J. 2017 Mar 24;7(3):e546. doi: 10.1038/bcj.2017.26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cardiomyopathies* / drug therapy
  • Cardiomyopathies* / mortality
  • Disease-Free Survival
  • Doxycycline / administration & dosage*
  • Female
  • Humans
  • Immunoglobulin Light-chain Amyloidosis* / drug therapy
  • Immunoglobulin Light-chain Amyloidosis* / mortality
  • Male
  • Middle Aged
  • Retrospective Studies
  • Survival Rate

Substances

  • Doxycycline